Obesity is associated with a cluster of metabolic disorders, low-grade inflammation and altered gut microbiota. Whether host metabolism is controlled by intestinal innate immune system and the gut ...
In a recent study published in the Journal of Experimental Medicine, researchers identified that individuals with a deficiency of myeloid differentiation primary response 88 (MyD88) and interleukin-1 ...
Brukinsa achieved higher complete or very good partial response rates than Imbruvica in MYD88-mutated Waldenström macroglobulinemia patients. Brukinsa demonstrated faster response times and more ...
Researchers have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Researchers have described ...
Researchers from Wenzhou Medical University and affiliated organizations presented the discovery and preclinical characterization of novel myeloid differentiation primary response 88 (MyD88) inhibitor ...
Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom macroglobulinemia. This is an ASCO Meeting Abstract from the 2012 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results